AMAG Pharmaceuticals Ret. on assets

What is the Ret. on assets of AMAG Pharmaceuticals?

The Ret. on assets of AMAG Pharmaceuticals, Inc. is -30.45%

What is the definition of Ret. on assets?



Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.

ttm (trailing twelve months)

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Ret. on assets of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals

What does AMAG Pharmaceuticals do?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Companies with ret. on assets similar to AMAG Pharmaceuticals